You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 4, April 1954 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CORTICOTROPIN, CORTISONE, THYROID, TESTOSTERONE IN SYPHILITIC INTERSTITIAL KERATITIS

JOSEPH V. KLAUDER, M.D.; GEORGE P. MEYER, M.D.

AMA Arch Ophthalmol. 1954;51(4):432-444.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THIS STUDY reports the results of the treatment of 36 patients (56 affected eyes) with acute syphilitic interstitial keratitis who received one or a combination of the following drugs, corticotropin, cortisone, extract thyroid, and testosterone.

Other treatment, except for the use of mydriatics, was withheld during administration of these agents in order more easily to evaluate their effect; but sooner or later, out of consideration for the welfare of the patient, we resorted to more efficacious therapy, namely, fever and antisyphilitic medicaments. Our previous experience with these older methods served as a control in judging the effectiveness of the newer ones.

Results of treatment were evaluated by the effect on the keratitis: the speed of clearing of the cornea, the time necessary for the eye to become quiet, the rate of improvement in visual acuity, and the best final vision. The real challenge in treatment is the elimination of resultant . . . [Full Text PDF of this Article]


Author Affiliations

PHILADELPHIA; CAMDEN, N. J.

From the Ocular Syphilis Clinic, Wills Eye Hospital, and the Division of Venereal Disease Control, Department of Public Health of Philadelphia.


Footnotes

Senior Consultant, Division of Venereal Disease Control, Department of Public Health of Philadelphia (Dr. Klauder).

This investigation was supported by a research grant, B-12 (C5), from the National Institute of Neurological Diseases and Blindness of the National Institutes of Health, United States Public Health Service.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1954 American Medical Association. All Rights Reserved.